参与CD3的双特异性抗体触发了对膜调节的T细胞招募波,以有效地杀死瘤
Chen-Yi Liao1, Patrick Engelberts2, Andreea Ioan-Facsinay2
1Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
Communications biology
|August 13, 2024
概括
针对CD3xHER2的双特异抗体 (bsAbs) 增强T细胞对固体瘤的免疫力. 抗体结合部位和度会影响T细胞的招募和瘤细胞的杀死,通过膜信号传递进行介导.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 两种特异性抗体 (bsAbs) 直接针对固体瘤的T细胞免疫力的确切机制尚不清楚.
- 了解T细胞的招募和瘤细胞的杀死对于优化基于bsAb的癌症疗法至关重要.
研究的目的:
- 研究CD3xHER2双特异抗体在固体瘤中的作用机制.
- 确定影响T细胞招募和由bsAbs.中介的瘤细胞溶解的关键因素.
主要方法:
- 查CD3xHER2bsAbs使用细胞外矩阵嵌入的乳腺癌瘤瘤阵列与健康的供体T细胞.
- 在6天的时间内观察T细胞的移动,招募和瘤杀伤.
- 评估bsAb亲和力,表皮质结合和度对T细胞中介细胞毒性的影响.
主要成果:
- 观察到分阶段的T细胞反应:随机运动,随后是bsAb依赖的招募,随后是瘤杀死.
- bsAb臂的低亲和力可以通过增加度来补偿,但表皮质结合部位至关重要.
- 有效的bsAbs结合膜近接的HER2表位素促进了瘤杀死,与那些结合远端表位素不同,尽管它们具有相似的亲缘关系.
- 最初的T细胞与瘤接触启动了T细胞通过膜信号征集的激增,在T细胞全面攻击之前.
结论:
- 在固体瘤中CD3xHER2 bsAbs的疗效取决于向的表位和初始T细胞参与.
- 膜信号驱动T细胞的招募,放大了抗瘤反应.
- bsAbs代表了一个有前途的治疗策略,具有关键的设计元素影响其体内活动.
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861